Lundbeck
HLUN-B.CO
#2797
Rank
NZ$10.87 B
Marketcap
NZ$10.96
Share price
-2.06%
Change (1 day)
5.60%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): NZ$1.29

According to Lundbeck's latest financial reports the company's current EPS (TTM) is NZ$1.26. In 2025 the company made an earnings per share (EPS) of NZ$0.85 an increase over its 2024 EPS that were of NZ$0.74.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.2951.53%
2025NZ$0.8514.5%
2024NZ$0.7429.29%
2023NZ$0.5823.09%
2022NZ$0.4737.26%
2021NZ$0.34-84.61%
2020NZ$2.21-24.61%
2019NZ$2.94-42.06%
2018NZ$5.0740.7%
2017NZ$3.60146.26%
2016NZ$1.46-120.48%
2015NZ-$7.143231.32%
2014NZ-$0.21-115.78%
2013NZ$1.36-23.36%
2012NZ$1.77-48.01%
2011NZ$3.41-9.68%
2010NZ$3.7713.72%
2009NZ$3.3224.32%
2008NZ$2.67-6.05%
2007NZ$2.8481.77%
2006NZ$1.56-16.76%
2005NZ$1.88-17.58%
2004NZ$2.28